BNP Paribas Financial Markets’s Palisade Bio PALI Stock Holding History

BNP Paribas Financial Markets’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$331K	Buy	+189,261	New	+$344K	﹤0.01%	3807
2015 Q2	–	Hold	0	–	-$3.15K	–	3598
2015 Q1	–	Hold	0	–	–	–	3369
2014 Q4	–	Hold	0	–	-$13.6K	–	2845
2014 Q3	–	Hold	0	–	–	–	3416

Other funds holding PALI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

BNP Paribas Financial Markets's PALI Position: Q1 2026 in Review

BNP Paribas Financial Markets opened a new position in Palisade Bio (PALI) in Q1 2026: 189,261 shares worth $331K. The stake represents ﹤0.01% of the portfolio and ranks #3807 among its holdings.

96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

BNP Paribas Financial Markets held 189,261 shares of Palisade Bio worth $331K as of Q1 2026.
Palisade Bio was a new BNP Paribas Financial Markets position in Q1 2026.
Palisade Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3807 holding.
96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.